Successfully identifying and targeting immune checkpoints on latently HIV-1-infected CD4
+ T cells could be a key component in HIV-1 eradication therapies [1, 2] . Immune checkpoints are negative regulators of: (i) T cell activation; (ii) T cell proliferation; and (iii) effector functions including cytokine production [3] . Thus, inhibiting immune checkpoints could influence the resting status of latently infected cells [1, 2] , which are key obstacles to curing HIV-1 [4, 5] . Candidate immune checkpoints in this regard include programmed cell death-1 (PD-1), T cell immunoreceptor with immunoglobulin and ITIM-domains (TIGIT), lymphocyte-activating protein-3 (LAG-3) and type-1 transmembrane immunoglobulin and mucin-3 (TIM3) [1, 2, [6] [7] [8] . Antibodies blocking immune checkpoints have been hypothesised to disrupt the resting status of T cells and hence have been utilised as latency-reversing agents [5, 7, 9] and may enhance CD8
+ T cell effector functions in HIV eradication trials [1, 2, [6] [7] [8] .
We propose that distinguishing between total and memory CD4 + T cell subsets is fundamental when interpreting data regarding HIV-1 DNA and immune checkpoints. To ensure clarity: 'total CD4 + T cells' refers to all CD3 + CD4 + lymphocytes and encompasses naïve and memory subsets; 'memory CD4 + T cells' includes the different memory subsets but excludes naïve cells (Figure 1a ).
Chomont et al. originally demonstrated that memory CD4
+ T cells highly expressing PD-1 were enriched for HIV-1 DNA [2] . This key finding inspired others to examine immune checkpoint expression on CD4 + T cells and subsequent studies described a positive correlation between multiple immune check points (TIGIT, PD-1, LAG-3 or TIM-3) and HIV-1 DNA in total CD4
+ T cells [10] [11] [12] . The rationale for examining immune checkpoints on total CD4
+ T cells appears strong given that HIV-1 DNA in total CD4
+ T cells is a crude but relatively reproducible approximation of the viral reservoir size. HIV-1 DNA also predicts time to viral rebound following analytical treatment interruption [13, 14] .
However, the original findings of Chomont et al. were from memory CD4 + T cells and subsequent studies have been from total CD4 + T cells. Therefore, we decided to analyse the expression of two immune checkpoints (PD-1 and TIGIT) on both total and memory CD4
+ T cells in a cohort of 22 aviraemic HIV-infected individuals on long-term ART, to elucidate whether memory subset proportions could be a confounding factor when performing the analyses in total CD4 + T cells (cohort previously described [15] ).
We found highly variable proportions of naïve and memory subsets between individuals (naïve CD4 + T cell range: 13-75%, Figure 1b ) as previously published [16, 17] . This variation exemplifies the heterogeneity in clinical cohorts encompassing HIV-infected individuals [18, 19] . As also shown by others, we demonstrated that PD-1 and TIGIT are almost exclusively expressed on memory
CD4
+ T cells [2, 8, 16] (Figure 1c ). To stress the importance of these findings, we ranked the 22 HIV-positive individuals according to the percentage of memory CD4 + T cells (low to high) ( Figure 1d ) and displayed the percentage of PD-1 or TIGIT-positive total CD4 + T cells for each individual (Figure 1e ). These data demonstrated that a low proportion of memory CD4 + T cells corresponded to a low PD-1 or TIGIT expression on total CD4
+ T cells, whereas a high proportion of memory CD4
+ T cells corresponded to high PD-1 or TIGIT expression on total CD4
+ T cells (Figures 1d, e) . This linkage is substantiated by a highly significant positive correlation between the size of the memory CD4 + T cell compartment and the percentage of total CD4
+ T cells expressing PD-1 or TIGIT (Figures 1f, g ).
Adding our analytic approach to the current knowledge, two essential points should be stressed: (1) + T cells (Figures 2a-d) . We estimated the magnitude of this change in r-value (Δr) using bootstrap analyses to estimate 95% confidence intervals (CI) and the permutation test to estimate P-values (Figure 2e + T cells is largely driven by the proportions of memory versus naïve cells. Therefore, we argue that it cannot be inferred that CD4 + T cells expressing immune checkpoint are enriched for HIV-1 DNA based on analyses performed in total CD4 + T cells.
In conclusion, these data reveal the importance of quantifying individual memory subsets when analysing immune checkpoints on CD4 + T cells in order to evaluate their usage as biomarkers of infected cells or when defining candidate immune checkpoint(s) for targeting during HIV-1 eradication strategies. This is a confounded interpretation. The confounding factor is that CD4 + T cell memory subset proportions are not taken into consideration using the analyses strategy in (a). 
